Sunshine Biopharma, Inc financial data

Symbol
SBFM, SBFMW on Nasdaq
Location
333 Las Olas Way, Cu4 Suite 433, Fort Lauderdale, FL
State of incorporation
Colorado
Fiscal year end
December 31
Former names
Mountain West Business Solutions, Inc (to 11/2/2009), mountain west business solutions,inc (to 10/19/2007), mountain state business solutions,inc (to 5/25/2007)
Latest financial report
10-Q/A - Q2 2024 - Aug 20, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 467 % -25.7%
Quick Ratio 118 % +93.8%
Debt-to-equity 27 % +34.8%
Return On Equity -16.1 % +84.8%
Return On Assets -12.7 % +85.6%
Operating Margin -15 % +92.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.22M shares -95.2%
Common Stock, Shares, Outstanding 1.17M shares -95.5%
Entity Public Float 10.7M USD -46.3%
Common Stock, Value, Issued 1.17K USD -95.5%
Weighted Average Number of Shares Outstanding, Basic 49.7M shares
Weighted Average Number of Shares Outstanding, Diluted 49.7K shares +292%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 30.5M USD +110%
Cost of Revenue 5.48M USD -40.4%
Research and Development Expense 1.71M USD +42%
General and Administrative Expense 13.8M USD -58.4%
Operating Income (Loss) -4.56M USD +83.7%
Nonoperating Income (Expense) 822K USD +14.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.74M USD +86.3%
Income Tax Expense (Benefit) -60.1K USD -116%
Net Income (Loss) Attributable to Parent -3.68M USD +86.7%
Earnings Per Share, Basic 76.7 USD/shares
Earnings Per Share, Diluted -2 USD/shares +74.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19.7M USD -52.7%
Accounts Receivable, after Allowance for Credit Loss, Current 2.03K USD +9146%
Inventory, Net 8.49M USD +99.7%
Assets, Current 25.7M USD -1.34%
Property, Plant and Equipment, Net 541K USD +47.7%
Operating Lease, Right-of-Use Asset 564K USD -20.7%
Intangible Assets, Net (Excluding Goodwill) 2.45M USD +98.4%
Goodwill 0 USD
Assets 29.3M USD +3.14%
Accounts Payable, Current 4.93M USD +180%
Liabilities, Current 5.3M USD +13.7%
Operating Lease, Liability, Noncurrent 463K USD -22.4%
Liabilities 5.81M USD +9.64%
Accumulated Other Comprehensive Income (Loss), Net of Tax -683K USD -203%
Retained Earnings (Accumulated Deficit) -65.7M USD -5.93%
Stockholders' Equity Attributable to Parent 23.5M USD +1.65%
Liabilities and Equity 29.3M USD +3.14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.19M USD -72.2%
Net Cash Provided by (Used in) Financing Activities 5.4M USD
Net Cash Provided by (Used in) Investing Activities -669K USD -357%
Common Stock, Shares Authorized 3B shares 0%
Common Stock, Shares, Issued 1.17M shares -95.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11.5M USD -41.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 6.4M USD +14.3%
Depreciation 50.9K USD +45.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -5.03M USD +81.3%
Property, Plant and Equipment, Gross 556K USD +16.3%
Operating Lease, Liability, Current 114K USD -6.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 109K USD -8.38%
Lessee, Operating Lease, Liability, to be Paid, Year One 115K USD -3.11%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 102K USD -8.89%
Deferred Tax Assets, Operating Loss Carryforwards 5.28M USD +22.1%
Preferred Stock, Shares Authorized 30M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 96.5K USD -8.89%
Additional Paid in Capital 89.8M USD +6.42%
Amortization of Intangible Assets 10.8K USD
Deferred Tax Assets, Net of Valuation Allowance 177K USD -41.3%
Interest Expense 145K USD +115%
Preferred Stock, Par or Stated Value Per Share 0.1 USD/shares